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ABSTRACT
Human exonuclease 1 (hEXO1) is implicated in DNA
mismatch repair (MMR) and mutations in hEXO1
may be associated with hereditary nonpolyposis
colorectal cancer (HNPCC). Since the subcellular
localization of MMR proteins is essential for proper
MMR function, we characterized possible nuclear
localization signals (NLSs) in hEXO1. Using fluor-
escent fusion proteins, we show that the sequence
418KRPR
421, which exhibit strong homology to other
monopartite NLS sequences, is responsible for
correct nuclear localization of hEXO1. This NLS
sequence is located in a region that is also required
for hEXO1 interaction with hMLH1 and we show that
defective nuclear localization of hEXO1 mutant
proteins could be rescued by hMLH1 or hMSH2.
Both hEXO1 and hMLH1 form complexes with the
nuclear import factors importin b/a1,3,7 whereas
hMSH2 specifically recognizes importin b/a3. Taken
together, we infer that hEXO1, hMLH1 and hMSH2
form complexes and are imported to the nucleus
together, and that redundant NLS import signals in
the proteins may safeguard nuclear import and
thereby MMR activity.
INTRODUCTION
Although initial recognition steps of DNA mismatch
repair (MMR), carried out by the hMSH2-hMSH6
(hMutSa), hMSH2-hMSH3 (hMutSb) and hMLH1-
hPMS2 (hMutLa) complexes, have been relatively well
studied, the nature of the downstream steps is less
characterized (1). One of these downstream steps is the
exonucleolytic removal of the DNA strand containing
the mispaired nucleotide by one or more exonucleases.
So far only a single exonuclease—human exonuclease 1
(hEXO1)—has been identiﬁed in humans (2). Due to
endonucleolytic activity of hMLH1 and 50-exonuclease
activity of hEXO1 bidirectional MMR can occur in the
presence of a single exonuclease (3–5). The coordinated
activity between proteins in the MMR pathway is
supported by the ﬁndings that speciﬁc interactions exist
between hEXO1 and hMutSa, hMutSb as well as
hMutLa; and that these interactions control enzymatic
activities (3–13). However, whether they are also impor-
tant for subcellular localization of the MMR proteins
remains to be elucidated.
Hereditary nonpolyposis colorectal cancer (HNPCC)
patients are characterized by defects in the MMR system.
In the majority of the patients, mutations are located in
one of the four MMR genes participating in the MutLS
complexes—hMLH1, hMSH2, hPMS2, and hMSH6—
with hMLH1 and hMSH2 accounting for the majority of
the disease-causing mutations (14). In the so-called
atypical HNPCC families that fulﬁll some but not all of
the Amsterdam criteria only a small proportion of
individuals exhibit mutations in any of the four MMR
genes (14). Germline variants of hEXO1 have been
detected in some patients with atypical HNPCC (15).
Moreover, Exo1 mutant mice are characterized by
reduced survival, increased susceptibility towards devel-
opment of lymphomas and increased mutation rates
(16,17). The phenotype of Exo1 mutant cells is compar-
able to MSH6 mutant cells and mutations in the human
homolog of this gene have been identiﬁed at a high
incidence in patients with atypical HNPCC (18–20). It is,
therefore, possible that a similar pathology may explain
the relation between hEXO1 mutations and HNPCC
development, resulting in late onset of disease, deviating
tumor spectrum and/or incomplete penetrance.
Polymorphisms in the hEXO1 gene may also have
relevance for the development of sporadic cancers.
Destabilization of MMR complex formation and the
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as well as the nature of hEXO1 and other MMR gene
variants (2).
Two splice variants hEXO1a (HEX1) and hEXO1b have
been identiﬁed and the transcripts give rise to proteins
with predicted molecular weights of 89 and 94kDa,
respectively. For the hEXO1 protein to participate in
MMR it needs to enter the nucleus. Molecules smaller
than  60kDa can passively diﬀuse through the nuclear
pore complexes (NPCs) into the nucleus, whereas import
of larger molecules requires speciﬁc nuclear localization
signals (NLSs) (21). The classical nuclear translocation
pathway is mediated by the importin a/b protein complex.
The initial cytoplasmic event is the binding of karyophilic
protein, via its NLS, to importin a subunit of the
heterodimeric receptor. The importin b subunit mediates
docking to the NPC followed by translocation into the
nucleus by association of importin b with Ran that
triggers dissociation (22). Presently, no deﬁnite NLS
consensus sequence has been determined, although NLS
sequences are frequently composed of basic amino acids
and may be classiﬁed as either mono- or bipartite (23).
It has recently been demonstrated that complex formation
between MMR proteins is crucial for nuclear import of
some of these proteins (24–26) but it is not clear if complex
formation between hEXO1 and hMSH2/hMLH1 inﬂu-
ences the subcellular localization of the proteins involved.
The hMLH1, hPMS2, hPMS1, hMSH3 and hMSH6
proteins but not hMSH2 contain potential NLS sequences
and some of them also contain nuclear export sequences
(NESs), which enable them to shuttle between nucleus and
cytoplasm (24,25,27).
The importance of correct subcellular translocation of
MMR proteins is highlighted by the fact that defects in
nucleocytoplasmic import of repair protein could confer a
MMR-deﬁcient phenotype. Along these lines, a signiﬁcant
number of HNPCC mutant proteins show no apparent
biochemical defects but cells containing these proteins are
nevertheless MMR deﬁcient (14). One explanation for this
phenotype could be that these HNPCC mutant proteins
show imperfect subcellular location. In order to investi-
gate the mechanism underlying nucleocytoplasmic import
of MMR proteins, we characterized possible NLS target-
ing signals in hEXO1. Using ﬂuorescent fusion proteins,
we show that the sequence
418KRPR
421 is responsible for
correct nuclear localization of hEXO1.
So far, only one importin b isoform has been identiﬁed
whereas six human importin as (importin a1,3,4,5,6,7)
have been described (28). These importin as seem to be
expressed ubiquitously with little tissue-speciﬁc variation.
They can be grouped into three subfamilies based on
sequence homology where importin a1 belongs to
subfamily 1, importin a3 to subfamily 2 and importin a7
to subfamily 3. It has been shown that the individual
importin as are able to import the same target proteins
(28) and that two competing substrates can change the
import capacity of importin as (29). Therefore, we found
it important to identify the individual importin as that are
responsible for nuclear import of the MMR proteins
hMSH2, hMLH1 and hEXO1. We show that both
hEXO1 and hMLH1 are able to form complex with
importin a1,3,7 whereas hMSH2 speciﬁcally recognizes
importin a3. Examination of the hEXO1 NLS mutant
proteins showed that these mutant proteins were able to
form complex with importin a3 despite its cytoplasmic
localization and that defective nuclear localization of the
NLS mutant proteins could be alleviated by co-expression
with either hMLH1 or hMSH2. These results suggest a
complex and strictly controlled mechanism for transloca-
tion of MMR proteins from cytoplasm to the nucleus.
Furthermore, our results suggest a possible mechanism for
tissue- or cell-type-speciﬁc discrimination of nuclear
translocation of MMR proteins.
MATERIALS AND METHODS
Plasmids
Plasmid pLJR115 expressing an NH2-terminal tagged
YFP-hEXO1b fusion protein (10) was used as a template
to construct a series of YFP-hEXO1 mutant proteins. The
hEXO1b allele contained in pLJR115 has previously been
described in (7,9,10,12,13). This allele diﬀers from other
frequently used hEXO1b alleles. The hEXO1b protein
used in our studies contains proline at position 757 instead
of leucine (P757L) otherwise the amino acid sequence of
hEXO1b is identical to the one expressed from hEXO1b
(Genbank: AAD13754). Mutations in hEXO1b were
introduced using QuikChange site-directed mutagenesis
according to the manufacturer’s guidelines (Stratagene,
La Jolla, CA). The DNA sequences of the entire coding
region of hEXO1b in the resulting constructs were veriﬁed
by DNA sequencing (ABI-Prism BigDye
TM Terminator
Cycle sequencing, Applied Biosystems). Oligonucleotide
primers (Supplementary data Table 1) used for site-
directed mutagenesis were purchased from Invitrogen.
For in vitro transcription translation (IVTT) of hEXO1
mutant protein K418A, plasmid pLJR129 (YFP-
hEXO1(K418A)) was digested with BamHI and SalI and
the fragment containing hEXO1(K418A) cloned into the
BamHI and XhoI site of pcDNA3.1A( ) (Invitrogen).
For IVTT of hEXO1 wild-type protein, pLJR115 (YFP-
hEXO1) was digested with BamHI and SalI and the
fragment containing hEXO1b cloned into the BamHI
and XhoI site of pcDNA3.1A( ) (Invitrogen). Other
plasmids pcDNA3-hMLH1, pcDNA3.1-hMSH2, pCITE-
hMSH2, pCITE-hMSH2(G674R), pCITE-hMSH2
(C697F) and pCITE-hMSH2(P622L) used for IVTT
have been described elsewhere (10,13; A. Lu ¨ tzen et al.,
submitted for publication). The plasmids containing the
importin a1, a3 and a7 was a gift from Dr Matthias
Ko ¨ hler (29). Importin a1 and a3 were cloned into pQE60
vector and importin a7 into pQE70. All importin
a constructs encode COOH-terminal His-tagged fusion
proteins. The plasmid containing the murine GST-tagged
importin b (pGEX HA-PTAC97) was a gift from
Dr Toshihiro Sekimoto (30).
The coding region of HEX1 was ampliﬁed with
the PCR Elongase system (Invitrogen) using primers
containing additional restriction enzyme sites, primer
pair (50-TAT GTC GAC ATG GGG ATA CAG GGA
TTG-30) and (50-GCA GGA TCC TCA GAA TTT TTT
2610 Nucleic Acids Research, 2007, Vol. 35, No. 8AAA TCC-30) was used for the PCR reaction. Plasmid
pSEL1(YFP-HEX1) was constructed by inserting PCR
fragment containing the HEX1 cDNA into the SalI and
BamHI sites of the pEYFP-C1 (CLONTECH) vector.
Mutations in pcDNA3.1A(-)-HEX1, used for pull-down
assays, were introduced with QuikChange site-directed
mutagenesis according to the manufacturer’s guidelines
(Stratagene, La Jolla, CA), using primers listed in
Supplementary data Table 2. The DNA sequences of the
entire coding region of HEX1 in the resulting constructs
were veriﬁed by DNA sequencing.
Confocal laser-scanning microscopy
Murine NIH-3T3 (MMRþ) and human HeLa (MMRþ)
cells were maintained as monolayer cultures in DMEM
(Gibco, Life Technologies). HCT116 (hMLH1-) and
HCT116þchr3 (MMRþ) were maintained in McCoy’s
5A medium (Gibco BRL, Life Technologies). All cell lines
were supplemented with 10% fetal bovine serum (FBS),
penicillin (50U/ml) and streptomycin (50mg/ml) (Gibco
BRL, Life technologies). HCT116þchr3 cells were
supplemented with 400mg/ml G418. All cell lines were
grown at 378C in a humidiﬁed atmosphere containing 5%
CO2. Transient transfections of YFP-hEXO1 and mutant
derivatives were performed with LipofectAMINE2000
(Life Technologies Inc., USA) according to the manufac-
turer’s instructions. Brieﬂy, 3 10
4 cells/cm
2 were seeded
on glass plates 24h prior to transfection incubated
overnight at 378C in a humidiﬁed 95% air–5% CO2
atmosphere. Cells were transfected with 2mg/ml of the
relevant plasmid and left for 24–48h before localization of
YFP proteins were examined with a confocal Zeiss
LSM510 microscope, as described in (31).
Western blot analysis of hEXO1 mutantproteins
For the western blot analysis, 8 10
5 exponentially
growing NIH-3T3 cells were seeded one day prior to
treatment. On the day of treatment, cells were transfected
using LipofectAMINE2000 (Life Technologies Inc., USA)
according to the manufacturer’s instructions with 14 mgo f
the relevant plasmid. Cells were incubated overnight.
Whole-cell extracts were prepared as described in
A. Lu ¨ tzen et al. (submitted for publication) and the
protein samples (12.5ml each) were analyzed by electro-
phoresis on 7% SDS polyacrylamide denaturing gel.
The protein bands were transferred to Hybond-P PVDF
(Amersham) membranes, and the membrane probed with
rabbit anti-GFP antibody (Ref 632377, dilution 1:500,
B.D. Clontech). The immunostained bands were visua-
lized using SuperSignal (Pierce, Illinois) western blotting
detection system.
In vitro transcriptionand translation
All IVTT reactions were carried out using the
TNT-coupled reticulocyte lysate system (Promega).
Brieﬂy, lysates were incubated with 1mg of plasmid,
amino acid mix lacking cysteine,
35S-Cysteine (Amersham
Biosciences) and T7 RNA polymerase for 90min at 308C
according to the manufacturer’s instructions. For IVTT
of unlabeled proteins
35S-Cysteine was substituted with
an amino acid mix lacking methionine. IVTT proteins
were resolved on 12% SDS polyacrylamide gels (Cambrex
Bio Science Rockland, Inc.) and exposed to X-ray ﬁlms
(Hyperﬁlm
TM MP, Amersham Biosciences).
GST-fusion interaction (pull-down) assay
All plasmids expressing recombinant proteins were
transformed into Escherichia coli BL21. For the
His-tagged importin as, the bacteria were grown at 378C
and induced with 1mM IPTG: importin a1 for 4h,
importin a3 for 6h, and importin a7 for 2h. The bacteria
were harvested by centrifugation and resuspended in
native binding buﬀer (20mM sodium phosphate; 0.5M
sodium chloride, pH 7.8), with protease inhibitors
(Complete Protease Inhibitor Cocktail Tablets, Roche).
The bacteria were lysed by French Press and the lysate
cleared by centrifugation 6000rpm for 15min and ﬁltered
using a 45-mm micron ﬁlter. About 20mM imidazole was
added to the lysate before it was loaded on an Ni-column
for puriﬁcation by the ProBound puriﬁcation system
(Invitrogen). For expression of GST-tagged importin b,
the culture was induced by 1mM IPTG at OD600¼0.6 for
2h at 378C. The bacteria were harvested by centrifugation
and cells were resuspended in PBS buﬀer containing
protease inhibitors. The GST-importin b fusion protein
was puriﬁed using Separose Beads 4B (Amersham
Bioscience), according to the manufacturer’s guidelines,
brieﬂy; 10ml of lysate was incubated with 1ml
beads for 2h at 48C. Then eluted using GEB buﬀer.
The GST-hMLH1 and GST-hMSH2 fusion proteins were
puriﬁed as described earlier (10). All the recombinant
proteins were stored at  808C with 10% glycerol
(Supplementary data Figure 3).
About 10ml( 1 mg) GST-hMLH1 (100mg/ml), GST-
hMSH2 (100mg/ml) or 2 mg importin b fusion proteins
were bound to 20ml GST beads (Glutathione
Sepharose
TM 4B, Amersham Biosciences) prepared in a
50% slurry with binding buﬀer (20mM Tris-HCl, pH 7.5,
10% glycerol, 150mM NaCl, 5mM EDTA, 1mM
dithiothreitol (DTT), 0.1% Tween 20 (polyoxyethylene-
sorbitan monolaurate), 0.75mg/ml BSA containing pro-
tease inhibitors by incubation for 2h at 48C on a rocking
platform. The protein-bound beads were washed three
times with binding buﬀer. Samples were transferred to a
5-ml tube (Falcon), diluted with binding buﬀer to 50ml
GST beads/ml and incubated for 30min at 48Co na
rocking platform. IVTT products were added to the
reaction mixture and incubated for 2h at 48C on a rocking
platform. Samples were washed three times with binding
buﬀer. If a second protein was added, this was done
after the wash and together with binding buﬀer; diluting
GST beads to 75ml GST beads/ml. Reactions were
incubated for additional 2h at 48C on a rocking platform.
Reaction mixtures were washed three times with binding
buﬀer before samples were resolved on 12% SDS
polyacrylamide gels (Cambrex Bio Science Rockland,
Inc.) and exposed to X-ray ﬁlms or visualized using
PhosphorImaging (STORM 840, Amersham Pharmacia
Biotech).
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GST beads were pre-loaded with importin b and
diluted to a ﬁnal concentration of 75ml beads/ml after
addition of both IVTT proteins. Importin a3 was
added and the beads incubated for 30min at 48C. About
10ml
35S-labeled IVTT protein was added and incubated
at 48C. After 90min, 5, 10, 20, 30, 50 or 100ml unlabeled
IVTT-hEXO1 proteins were added and incubated at
48C for 90min. The beads were washed and analyzed
as described above. The intensity of the bands was
determined using IMAGEQUANT 5.2 (Molecular
Dynamics).
RESULTS
Identification of hEXO1 nuclearlocalization signal
To identify the region(s) responsible for nuclear localiza-
tion of hEXO1, we screened the amino acid sequence for
possible NLS targeting signals and identiﬁed three
putative NLS sequences (Figure 1). To clarify the
functional signiﬁcance of these three putative NLS
sequences each of them were mutated in a series of
YFP-hEXO1 constructs (Figure 1A) that were transiently
expressed in NIH-3T3 cells. To verify that the YFP-
hEXO1 mutant proteins were properly processed and not
degraded, we measured the protein expression of the
ﬂuorescent fusion proteins by western blot analysis
(Supplementary data Figure 1). All mutant proteins
exhibited the correct size corresponding to full-length
YFP-hEXO1 fusion proteins suggesting that these YFP-
fusion proteins were not degraded. The subcellular
localization of the YFP fusion proteins was examined
by confocal microscopy (Figure 2). As shown earlier (12)
two diﬀerent YFP-hEXO1 patterns were observed in
cells transfected with YFP-hEXO1 — either (i) distinct
nuclear foci or a (ii) diﬀuse nuclear staining. The
diﬀuse nuclear staining is observed in non-S-phase cells
as judged by the absence of PCNA foci (12, data
not shown).
None of the examined amino acid changes in the
putative NLS sequences
290PIKRKLI
296 and
775KRKH
778
(292KRG and 772KRG) had any eﬀect on nuclear
localization of the hEXO1 mutant proteins (Figure 2,
panels 2 and 3). In contrast, when the
418KRPR
421
sequence was mutated, three of the mutant proteins were
localized in cytoplasm (Figure 2, panels 5–10), showing
that this region is necessary for correct nuclear localiza-
tion of hEXO1. It is well documented that the ﬁrst lysine
in the proposed consensus NLS sequence K(K/R)X(K/R)
is critical for importin-a-mediated nuclear import (32–35),
and substitution of the basic lysine residue to alanine,
threonine or asparagine completely blocks the nuclear
import of the speciﬁc protein (36). Consistent with these
observations, we ﬁnd that substitutions K418T and
K418A in hEXO1 resulted in cytoplasmic localization of
the mutant proteins. The same defect in nuclear localiza-
tion was observed when we changed the basic arginine
Figure 1. Exonuclease 1 gene structure. (A) The N (N-terminal) and I (internal) domains necessary for exonuclease activity as well as the regions
important for protein–protein interaction with hMSH2, hMSH3 and hMLH1 are pointed out. The three putative NLS sequences
290PIKRKLI
296,
418KRPR
421,
775KRKH
778 in hEXO1 are shown in boxes and the individual amino acids change introduced in these regions are shown below.
(B) Sequence alignment of the putative NLS regions from human (Genbank: CAB45733, AAC33874, AAC63043, AAC69880, NP_003677,
AAD13754, CAI15658, AAN39382, NP_006018), chimpanzee (Genbank: XP_514304), dog (Genbank: XP_547491), mouse (Genbank: NP_036142),
chicken (Genbank: XP_419550), Xenopus (Genbank: AAH84102), zebraﬁsh (Genbank: NP_998634) and rat (Genbank: XP_222932). Identical amino
acids are shown in bold and numbers indicate the position of the residues in the respective proteins.
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panel 8). Along these lines, we observed normal nuclear
localization and formation of nuclear foci, when we
changed the proline at position 420 to alanine (P420A)
as well as arginine to alanine at position 421 (R421A)
(Figure 2, panels 9 and 10).
The
418KRPR
421 sequence of hEXO1 shows similarity
with both mono- and bipartite NLS sequences. Bipartite
NLS would require a basic cluster of amino acids 10–12
amino acids upstream or downstream of the
418KRPR
421
sequence. There is no indication of such a cluster
upstream, but a basic cluster
440KKTKK
444 is located 21
amino acids downstream of the
418KRPR
421 sequence.
To determine if the proposed hEXO1 NLS
sequence
418KRPR
421 is mono- or bipartite, we changed
a single residue upstream (K413T) as well as downstream
(K440T) of this sequence. None of the mutations had any
eﬀect on nuclear localization of the mutant proteins
(Figure 2, panels 4 and 11) demonstrating that the
418KRPR
421 sequence is a monopartite NLS sequence of
hEXO1.
HumanMMR proteins recognize specific nuclear
import factors
In order to characterize the basic molecular mechanism
underlying import of MMR proteins into the nucleus, we
examined which of the importin as that were able to form
a complex with the repair proteins. Using a pull-down
assay we show that both hEXO1 and hMLH1, which
contain classical NLS sequences, are able to form
complexes with importin as from all three subfamilies
(a1,3,7) as well as with importin b alone (Figure 3A
and C). In contrast, we could not detect any complex
formation between hMSH2 and importin a1, a7o rb. The
MSH2 protein, which does not contain any classical NLS
sequences, only formed complex with importin a3
(Figure 3B).
We also used the pull-down assay to clarify if the
cytoplasmic localization of the hEXO1 NLS mutant
proteins is due to the inability of these proteins to form
complexes with the importin as. We found that the
cytoplasmic hEXO1(K418A) NLS mutant protein formed
complexes with all importin as tested as well as with
importin b similar to the wild-type protein (Figure 3A).
This result suggests that the cytoplasmic localization of
Figure 2. Nuclear localization of YFP-hEXO1 and mutant hEXO1
proteins. NIH-3T3 cells were transiently transfected with 2mg/ml of
the constructs (1) hEXO1, (2) hEXO1(292KRG), (3)
hEXO1(772KRG), (4) hEXO1(K413T), (5) hEXO1(K418R), (6)
hEXO1(K418A), (7) hEXO1(K418T), (8) hEXO1(R419A), (9)
hEXO1(P420A), (10) hEXO1(R421A), (11) hEXO1(K440T), (12)
hEXO1(L410R), (13) hEXO1(T439M), (14) hEXO1(P757L), (15)
hMLH1, (16) hMSH2, (17) hEXO1 and hMLH1, (18) hEXO1 and
hMSH2, (19) hEXO1(K413T) and hMLH1 and (20) hEXO1(K418A)
and hMLH1. Cells were left overnight before the distribution of YFP-
and CFP-tagged proteins was examined by confocal laser scanning
microscopy and Nomarski contrast. YFP-tagged proteins (red), CFP-
tagged proteins (green) and co-localization of ﬂuorescent fusion
proteins (yellow).
Figure 3. Interactions between importin as and MMR proteins.
(A) Lane 1: hEXO1(K418A); 2: hEXO1; 3: beads þ vector; 4:
beadsþhEXO1(K418A); 5: beadsþhEXO1; 6: E. coli
lysateþhEXO1(K418A); 7: bþhEXO1(K418A); 8: bþhEXO1; 9:
bþE. coli lysateþhEXO1(K418A); 10: bþE. coli lysateþhEXO1; 11:
bþa1þhEXO1(K418A); 12: bþa1þhEXO1; 13: E. coli lysateþa1þ
hEXO1(K418A); 14: bþa3þhEXO1(K418A); 15: bþa3þhEXO1; 16:
E. coli lysateþa3þhEXO1(K418A); 17: bþa7þhEXO1(K418A); 18:
bþa7þhEXO1; 19: E. coli lysateþa7þhEXO1(K418A). (B)L a n e1 :
hMSH2; 2: beadsþv e c t o r ;3 :b e a d s þhMSH2; 4: bþa1þhMSH2; 5:
E. coli lysateþa1þhMSH2; 6: bþa3þhMSH2; 7: E. coli lysateþa3þ
hMSH2; 8: bþa7þhMSH2; 9: E. coli lysateþa7þhMSH2;
10: bþhMSH2. (C)L a n e1 :h M L H 1 ;2 :b e a d s þvector; 3:
beadsþhMLH1; 4: E. coli lysateþhMLH1; 5: bþa1þhMLH1; 6:
E. coli lysateþa1þhMLH1; 7: a1þhMLH1; 8: bþa3þhMLH1;
9: E. coli lysateþa3þhMLH1; 10: a3þhMLH1; 11: hMLH1; 12:
bþa7þhMLH1; 13: E. coli lysateþa7þhMLH1; 14: a7þhMLH1;
15: bþhMLH1; 16: E. coli lysateþbþhMLH1.
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of these proteins to recognize the nuclear import factors.
hEXO1 enhance nuclear foci formations of
hMLH1and hMSH2
It has been shown that complex formation between
hMLH1 and hPMS2/hPMS1 is essential for correct
nuclear translocation of the PMS proteins (24,25).
In vitro results suggest that hEXO1 forms ternary
complexes with both hMLH1-hPMS2 and hMSH2-
hMSH6 via direct protein–protein interaction between
hEXO1-hMLH1 and hEXO1-hMSH2 (12,13). These
complex formations are critical for MMR activity, but it
is not clear whether they play roles in subcellular
localization of the MMR complexes. To investigate if
hMSH2 and hMLH1 inﬂuence subcellular localization
of hEXO1, we examined cells co-transfected with
CFP-hMSH2 and YFP-hEXO1 as well as CFP-hMLH1
and YFP-hEXO1 (Figure 2, panels 17 and 18). As shown
earlier two diﬀerent patterns were observed in cells
transfected with YFP-hEXO1 (i) distinct nuclear foci or
a (ii) diﬀuse nuclear staining (13, data not shown;
Figure 2). In contrast, we did not observe any discrete
nuclear punctuates in cells transfected solely with
CFP-hMLH1 or CFP-hMSH2 (Figure 2, panels 15
and 16). When cells were co-transfected with either
YFP-hEXO1 and CFP-hMSH2 or YFP-hEXO1 and
CFP-hMLH1, the formation of nuclear foci was increased
(Figure 2, Table 1); indicating that complex formation
between hEXO1 and hMLH1 or hMSH2 aﬀects the
distribution of the MMR protein in nucleus. The hEXO1
protein is not critical for nuclear import of hMLH1 and
hMSH2. However, since NIH-3T3 cells express MMR
proteins and it has been shown that murine homologs can
form complexes with the human proteins (24) it is possible
that the endogenously expressed MMR proteins in NIH-
3T3 cells could aﬀect the distribution of hEXO1.
Therefore, we expressed YFP-hEXO1 in the human cell
lines HeLa (MMR proﬁcient), HCT116 (deﬁcient in
hMLH1) as well as in HCT116þchromosome 3 (proﬁ-
cient in hMLH1). We observe the same localization
pattern as in NIH-3T3 cells for all cell lines tested
(data not shown).
To address whether the presence of hMLH1 and
hMSH2 in the nucleus promotes the localization of
hEXO1 in foci, we repeated the experiment shown in
Figure 2 (panels 17 and 18) using the NLS-deﬁcient
hEXO1(K418A) as well as the NLS-proﬁcient
hEXO1(K413T) proteins (Table 1). The hEXO1(K418A)
mutant protein is unable to localize to nucleus as shown in
Figure 2 (panel 6) and, therefore, we did not expect
enhanced nuclear foci formation in cells co-expressing
YFP-hEXO1(K418A) with either CFP-hMLH1 (Figure 2,
panel 20; Table 1) or CFP-hMSH2 (data not shown;
Table 1). However, in contrast to cells transfected with
YFP-hEXO1(K418A) alone, a signiﬁcant portion of
this fusion protein was however visible in the nucleus
and co-localized with CFP-hMLH1 in discrete nuclear
punctuates (Figure 2, panel 20; Table 1). The same
subcellular localization pattern was observed when
Figure 4. (A) Interaction between hEXO1(K418A) and hMLH1/
hMSH2. Lane 1: beadsþhEXO1(K418A); 2: E. coli lysateþIVTT
hEXO1(K418A); 3: GST-hMSH2þvector; 4: GST-hMLH1þvector; 5:
GST-hMSH2þhEXO1(K418A); 6: GST-hMSH2þhEXO1; 7: GST-
hMLH1þhEXO1(K418A); 8: GST-hMLH1þhEXO1; 9:
hEXO1(K418A); 10: hEXO1. (B) Interaction between hEXO1
(K418A) and importin a3. Lane 1: hEXO1(K418A); 2: beadsþ
hEXO1(K418A); 3: a3/bþhEXO1(K418A); 4: a3/bþhEXO1(K418A)
þunlabeled hEXO1 (1:0.5); 5: a3/bþhEXO1(K418A)þunlabeled
hEXO1 (1:1); 6: a3/bþhEXO1(K418A)þunlabeled hEXO1 (1:2); 7:
a3/bþhEXO1(K418A)þunlabeled hEXO1 (1:3); 8: a3/bþhEXO1
(K418A)þunlabeled hEXO1 (1:5); 9: a3/bþhEXO1(K418A)þunla-
beled hEXO1 (1:10); 10: hEXO1; 11: beadsþhEXO1; 12: a3/bþ
hEXO1; 13: a3/bþhEXO1þunlabeled hEXO1 (1:0.5); 14: a3/
bþhEXO1þunlabeled hEXO1 (1:1); 15: a3/bþhEXO1þunlabeled
hEXO1 (1:2); 16: a3/bþhEXO1þunlabeled hEXO1 (1:3); 17: a3/
bþhEXO1þunlabeled hEXO1 (1:5); 18: a3/bþhEXO1þunlabeled
hEXO1 (1:10). (C) Relative intensity of bands shown in (B) as a
function of unlabeled IVTT-hEXO1/labelled IVTT-hEXO1/hEXO1
(K418A). Open circles: labeled hEXO1 competed with excess unlabeled
hEXO1; closed circles: labeled hEXO1(K418A) competed with excess
unlabeled hEXO1. Standard deviations are shown. Each data point in
this ﬁgure represents the average from three independent experiments.
Table 1. hEXO1 nuclear localization and formation of nuclear speckles
in the presence of hMLH1 or hMSH2
Vector
a Nuclear
localization
b
Nuclear
Speckles
b
pYFP-hEXO1 92 (5) 15 (5)
pCFP-hMLH1 92 (7) 4 (6)
pCFP-hMSH2 95 (7) 2 (5)
pYFP-hEXO1(K413T) 94 (8) 9 (8)
pYFP-hEXO1(K418A) 0 (0) 0 (0)
pYFP-hEXO1þpCFPhMLH1 98 (5) 45 (12)*
pYFP-hEXO1þpCFPhMSH2 100 (0) 67 (10)*
pYFP-hEXO1(K413T)þpCFP-hMLH1 100 (0) 39 (5)*
pYFP-hEXO1(K413T)þpCFP-hMSH2 100 (0) 55 (16)*
pYFP-hEXO1(K418A)þpCFP-hMLH1 50 (18)*
# 31 (13)
pYFP-hEXO1(K418A)þpCFP-hMSH2 76 (17)*
# 60 (10)*
aThe indicated CFP- or YFP-tagged constructs were transfected into
NIH-3T3 cells and examined by confocal microscopy.
bAt least ﬁve
consecutive visual ﬁelds corresponding to approximately 150 cells were
counted. The results are stated as mean and SD (in brackets). *P50.05
(Student t-test, two tailed, equal variance).
#In all cells, cytoplasmic
YFP-hEXO1(K418A) and CFPh-MLH1 or CFPh-MMSH2 were
observed and the corresponding number indicates the percentage of
cells with increased levels of speckled or diﬀuse nuclear staining
compared to controls (YFP-hEXO1(K418A)).
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hMSH2 although the nuclear foci formation was more
pronounced for the CFP-hMLH1 co-transfections
(data not shown). Interestingly, we found that the NLS-
defective YFP-hEXO1(K418A) mutant proteins only
translocated to the nucleus when hMSH2 or hMLH1
formed nuclear foci. In cells showing diﬀuse nuclear
staining of hMSH2 or hMLH1, the hEXO1(K418A)
mutant protein remained in cytoplasm (data not shown).
Furthermore, we did not observe any hEXO1-N
(hEXO1 NH2-terminal YFP-fusion protein that does not
contain the NLS as well as the hMLH1-interacting
domain and which localizes to cytoplasm (13)) in nucleus
when this fusion protein was co-expressed with CFP-
hMLH1 (data not shown). It has been shown earlier
that hEXO1 does not interact with hPMS2 (10). We also
found that in cells co-expressing YFP-hEXO1(K418A)
and CFP-hPMS2 the NLS-defective hEXO1 mutant
protein localized in cytoplasm (data not shown).
Our results suggest that the NLS-defective hEXO1
mutant proteins are able to form complexes with
hMSH2 and hMLH1 but not hPMS2.
The hEXO1 NLS sequence is located in the domain
required for interaction with hMLH1 (Figure 1), thus
we further investigated the ability of the hEXO1(K418A)
protein to form complex with hMLH1 and hMSH2 in the
in vitro pull-down assay. We show that hEXO1(K418A)
can form a complex with both hMLH1 as well as hMSH2
in this assay (Figure 4A). These results suggest that either
(i) hMSH2 and hMLH1 are able to co-translocate
hEXO1(K418A) into nucleus in the lack of a functional
hEXO1 NLS sequence or that (ii) YFP-hEXO1(K418A)
fusion protein is quickly exported to cytoplasm if is it
is not in complex with hMLH1 or hMSH2. A third
(iii) possibility would be that the complex formation
between hEXO1(K418A) and importin a is less eﬃcient
than the similar protein–protein interaction between the
importin a and the wild-type hEXO1 proteins resulting
in cytoplasmic retention of the hEXO1(K418A)
mutant protein. In order to test the third possibility,
we performed a pull-down assay where we labeled either
hEXO1(K418A) or hEXO1 and incubated these proteins
with importin a3/b complex. To compare complex
formations between importin a3/b and hEXO1(K418A)
or hEXO1, we added increasing amounts of unlabeled
IVTT-hEXO1 or puriﬁed hEXO1 to compete for binding
with the labeled proteins (Figure 4B, Supplementary data
Figure 4B) or included the competitor during (rather than
after) complex formation (Supplementary data
Figure 4A). We did not ﬁnd any major diﬀerence in
complex formation between importin a3/b and the
hEXO1 proteins suggesting that the hEXO1 NLS
mutant proteins do not have lower aﬃnity for the nuclear
import factors (Figure 4C).
Subcellular localization ofHEX1(hEXO1a)
The hEXO1 gene generates two splice variants, HEX1
(hEXO1a) and hEXO1b, which encode polypeptides of 803
and 846 amino acids, respectively (2). Both isoforms
contain the exonucleolytic domain and so far no biological
or biochemical diﬀerences between the two proteins have
been reported. We have shown earlier that the COOH-
terminal region of hEXO1 is essential for correct nuclear
localization as well as for the co-localization of hEXO1b
with PCNA during S-phase (10,13). Therefore, it is
possible that the two diﬀerent hEXO1 splice variants
diﬀer in subcellular localization pattern. The short splice
variant of the human exonuclease 1, HEX1 (hEXO1a),
diﬀers from hEXO1b by lacking the last 43 COOH-
terminal amino acids. Since subcellular localization of
HEX1 and co-localization with PCNA have not been
addressed earlier, we examined if there were any
diﬀerences in the subcellular localization of HEX1 and
hEXO1b. Results presented in Figure 5 demonstrate that
like hEXO1b the subcellular localization of HEX1 is
restricted to the nucleus and that HEX1 co-localizes with
PCNA. Moreover, we infer that both splice variants of
hEXO1 may be involved in processes where interactions
with PCNA are required, i.e. DNA replication and/or
MMR. Although the COOH-terminal part of hEXO1b is
Figure 5. Subcellular localization of HEX1. Fusion proteins were visualized by confocal imaging. (A) NIH3T3 cells transfected with YFP-HEX1.
(B) NIH-3T3 cells co-transfected with YFP-HEX1 and CFP-PCNA. (I) Transfected cell in S-phase, 1: CFP-PCNA; 2: YFP-HEX1; 3: Normaski
image; and 4: Overlay of CFP-PCNA and YFP-HEX1. (II) Transfected cell not in S-phase, 5: CFP-PCNA; 6: YFP-HEX1; 7: Normaski image;
and 8: Overlay of CFP-PCNA and YFP-HEX1.
Nucleic Acids Research, 2007, Vol. 35, No. 8 2615crucial for subcellular localization, the 43 COOH-terminal
amino acids have no inﬂuence on the subcellular localiza-
tion of hEXO1.
Subcellular localization and proteincomplex formationof
hEXO1 variantproteins
Deﬁciency in MMR can be a result of both defective
protein–protein interaction (complex formation) and
defective subcellular localization of MMR proteins.
In order to characterize variants of the hEXO1 gene,
we included two variants, V27A and L410R, which have
been identiﬁed only in HNPCC patients, and could
therefore represent pathogenic mutations. The remaining
R354H, T439M, K589G, G670E and P757L variants,
were identiﬁed with same frequency in patients and
control individuals (15) and may be considered as
naturally occurring polymorphisms, although the
hEXO1 genotypes T439M and P757 have been shown to
be correlated with development of colorectal cancer (37).
None of the amino acids substituted in the hEXO1
variants are located in the putative NLS sequences.
However, L410R is located in the vicinity of the functional
NLS sequence
418KRPR
421 and T439M near the basic
440KKTKK
444 cluster located 21 amino acids downstream
of the
418KRPR
421 sequence. Figure 2 shows that the
localization of YFP-hEXO1 variant proteins is restricted
to the nucleus and resembles the pattern observed for
wild-type YFP-hEXO1.
We have shown earlier that hEXO1 can form ternary
complexes with both hMutSa and hMutLa and that these
protein–protein interactions control both the biochemical
activity of the proteins as well as the subcellular
localization of the exonuclease (12,13; Figure 2;
Table 1). In order to investigate if the hEXO1 variants
act diﬀerently regarding complex formation with other
MMR proteins, we investigated the ability of the variants
to interact with hMSH2, hMLH1 as well as hMutSa and
hMutLa (Figure 6). Our results show that all HEX1
variant proteins interact with GST-hMLH1 as well as with
GST-hMSH2 (Figure 6A and B). Furthermore, the
variants HEX1-L410R and HEX1-T439M interact with
hMutSa and hMutLa suggesting that these proteins can
form ternary complexes with hMutSa and hMutLa like
the wild-type protein (Figure 6C and data not shown).
Under the experimental conditions employed, the
GST-MMR proteins, which are bound to the beads, are
saturated with the ﬁrst added protein (hMSH6 or hPMS2)
before the second protein (hEXO1) is added to the
reaction mixture. However, it cannot be completely
excluded that some of the pre-incubated protein may
dissociate and become exchanged with the second protein.
In conclusion, our results indicate that if the described
HEX1 variants are pathogenic this can neither be
explained by defective hMLH1 or hMSH2 protein
interaction nor abnormal subcellular localization.
DISCUSSION
In this article, we examined the nuclear translocation of
hEXO1. These types of studies are important for
(i) understanding the basic molecular mechanisms
underlying MMR as well as for (ii) identiﬁcation of the
multiple ways by which the MMR pathway can be
inactivated. The latter may have implications for diagnosis
of HNPCC.
As a ﬁrst step to understand the molecular
mechanisms underlying subcellular movements of
MMR proteins, we investigated the function of three
putative NLS sequences
290PIKRKLI
296,
418KRPR
421 and
775KRKH
778 in hEXO1. None of these are located in the
N and I regions required for exonuclease activity, but they
are conserved among hEXO1 proteins of higher
eukaryotes (Figure 1B) suggesting a biological role of
these sequences. Mutations in critical residues of the
418KRPR
421 sequence in hEXO1 resulted in loss of nuclear
translocation—in particular residues K418 and R419 are
essential for nuclear targeting. These lysine and arginine
residues are included in a consensus NLS sequence
that presumably binds to importin as 1, 3 and 7.
At least two types of NLS sequences have been identiﬁed
namely the mono- and bipartite NLS. The basic
440KKTKK
444 cluster located 21 amino acids downstream
of the
418KRPR
421 sequence, could be part of a major
binding site. This would imply that the K418 residue
takes part in a minor binding site of the bipartite NLS
sequence. However, mutations in the minor binding site
Figure 6. Interaction between hEXO1 variants and hMLH1, hMSH2
and hMSH2/hMSH6. (A) Lane 1: hMLH1þHEX1-V27A; 2: hMLH1
þHEX1-R354H; 3: hMLH1þHEX1-L410R; 4: hMLH1þHEX1-
T439M; 5: hMLH1þHEX1-K589E; 6: hMLH1þHEX1-G670E.
(B) Lane 1: hMSH2þHEX1-V27A; 2: hMSH2þHEX1-R354H;
3: hMSH2þHEX1-L410R; 4: hMSH2þHEX1-T439M; 5: hMSH2
þHEX1-K589E; 6: hMSH2þHEX1-G670E. (C) Lane 1: hMSH2
þhMSH6; 2: hMSH2þHEX1; 3: hMSH2þhMSH6þHEX1 (hMSH6
and HEX1 were added to hMSH2 simultaneously); 4: hMSH2
incubated for 2h with HEX1 followed by 2h incubation with
hMSH6; 5: hMSH2 incubated for 2h with hMSH6 followed by 2h
incubation with HEX1; 6: hMSH2 incubated for 2h with HEX1
followed by 2h incubation with unlabeled hMSH6; 7: hMSH2
incubated for 2h with unlabeled hMSH6 followed by 2h incubation
with HEX1; 8: hMSH2 incubated for 2h with unlabeled HEX1
followed by 2h incubation with hMSH6; 9: hMSH2 incubated for 2h
with hMSH6 followed by 2h incubation with unlabeled HEX1. Control
reactions were performed as described in (12) (data not shown).
Samples were resolved on 12% SDS-PAGE gel and imaged by
exposure to X-ray ﬁlms.
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on protein translocation (38). Furthermore, the distance
between the putative major and minor binding site in
hEXO1 is larger than the expected 10–12 amino acids and
the K440T mutant protein localizes similar to wild-type
hEXO1. Taken together our results show that the
418KRPR
421 sequence is a monopartite NLS sequence.
The hMSH2 protein does not contain classical NLS
sequences (data not shown) and, therefore, it is possible
that this MMR protein translocates into the nucleus in
complex with other proteins similar to hMutLa and
hMutLb (24–26). The fact that hMSH2 does not contain a
classical NLS is surprising since this MMR protein
localizes to the nucleus when overexpressed as a
CFP-hMSH2 fusion protein (Figure 2) and it forms a
complex with nuclear import factors importin a3/b in vitro
(Figure 3). Interestingly, our results show that unlike
hEXO1 and hMLH1, which both recognize several
importin as, hMSH2 speciﬁcally forms a complex with
importin a3. In order to identify the sequence responsible
for nuclear translocation of hMSH2, we identiﬁed two
mutations P622L and C697F in hMSH2 that result in
cytoplasmic localization of the proteins (A. Lu ¨ tzen et al.,
submitted for publication). However, when these mutant
proteins were tested in the pull-down assay for interaction
with importin a3/b, they formed complexes with the
nuclear import factors similar to the wild-type protein
(Supplementary data Figure 2). These results suggest
that the mechanisms underlying nuclear import of the
individual MMR proteins are diﬀerent, which could play
an important biological role in regulation of MMR
activity.
Protein–protein interactions between hEXO1, PCNA,
RPA, RFC and hMutSa and hMutLa are important
for regulation of overall repair activity (4). However,
it is unclear if these protein–protein interactions are
also important for subcellular localization of the
MMR proteins. We therefore addressed whether the
co-expression of hEXO1 and hMLH1 or hMSH2 would
alter the subcellular distribution of these proteins. A clear
increase in the formation of nuclear foci was observed
upon co-transfection indicating that complex formation
facilitates proper localization (Figure 2; Table 1). This was
even observed with the hEXO1(K418A) mutant protein,
which alone is unable to localize to nucleus. It was further
demonstrated that hEXO1(K418A) forms complex with
hMLH1 and hMSH2. We measured co-localization of
PCNA with hEXO1 as well as PCNA with hMLH1 (data
not shown) and we did not detect any increase in the
percentage of S-phase cells suggesting that co-expression
of hEXO1 and hMLH1 does not stimulate cell prolifera-
tion. We have shown earlier (13) that not all foci represent
replication foci and, therefore, we cannot conclude that
the punctuate staining observed in this work represents
replication factories. Examples of a similar piggy-back
mechanism where NLS-dysfunctional proteins can be
translocated to the nucleus through complex formation
with proteins containing functional NLS sequences are
known from other repair proteins such as for the
KU70/80 kinase and MRN (hMRE11-hRAD50-NBS1)
complexes, which are involved in double-stranded
break repair (39,40). Taken together the results support
the idea that hEXO1, hMLH1 and hMSH2 form
complexes, which under certain conditions are imported
together and that redundant NLS import signals in the
proteins may safeguard import and MMR activity.
Mutations located outside the NLS sequence could
alter the protein conformation in a way that makes the
NLS sequence inaccessible to importin binding. Therefore,
we found it relevant to examine sequence variations in
the hEXO1 gene from cancer patients in or near the
418KRPR
421 sequence and determine the subcellular
localization of these mutant proteins. Our results show
that all hEXO1 variant proteins examined localized to
the nucleus similar to the wild-type protein. The L410R
variation in particular has been found in atypical HNPCC
patients (15). The mutant is translocated to the nucleus
similar to wild-type hEXO1 (Figure 2), but it is defective
in exonuclease activity despite the fact that the mutation is
located within the hEXO1-hMLH1-binding domain and
does not seem to have any eﬀect on complex formation
between these two proteins (41, Figure 6). Overall,
these results suggest that the hEXO1-L410R mutant
protein could act as a potential dominant negative
resulting in defective MMR activity in individuals carry-
ing this allele.
Finally, our results demonstrate no functional diﬀer-
ence between HEX1 and hEXO1b with respect to
subcellular localization and co-localization with PCNA.
It can therefore be concluded that the 43 COOH-terminal
amino acids are not involved in nuclear localization
signaling. The HEX1 protein is capable of interacting with
both hMLH1 and hMSH2 (Figure 6) and it has been
established that HEX1 is capable of forming a ternary
complex with hMutLa and hMutSa (data not shown;
Figure 6), as demonstrated to apply for hEXO1b (11,12).
The results presented demonstrate that all six HEX1
mutants V27A, R354H, L410R, T439M, K589E and
G670E are able to interact with both hMLH1 and hMSH2
and in addition, that amino acid substitutions L410R and
T439M do not interfere with the ability of HEX1 to
participate in ternary complex formation with hMutLa
or hMutSa.
In conclusion, we have identiﬁed the sequence
418KRPR
421, which exhibit strong homology to other
monopartite NLS sequences to be responsible for correct
nuclear localization of hEXO1. We have shown that
hEXO1 and hMLH1 are recognized by nuclear import
factors importin a1,3,7/b whereas hMSH2 is speciﬁcally
recognized by importin a3/b. These results suggest
diﬀerences in the mechanisms underlying nuclear translo-
cation of MMR proteins. We also showed that co-
expression of hEXO1 NLS mutant proteins with either
hMLH1 or hMSH2 restored nuclear localization of
hEXO1 NLS mutant proteins. Our results suggest that
hEXO1, hMLH1 and hMSH2 form complexes, which are
imported to the nucleus together. However, complex
formations between these MMR proteins are not essential
for nuclear translocation implying that redundant
NLS import signals in the proteins may ensure nuclear
import and thereby MMR activity. It can be speculated
that repair proteins that either lack a functional NLS
Nucleic Acids Research, 2007, Vol. 35, No. 8 2617or do not contain sequences that bind importin ab
form complexes in the cytoplasm before nuclear import.
Such mechanism would safeguard nuclear import of
proteins since karyophilic proteins would increase nuclear
localization upon complex formation, instead of indivi-
dually competing for interaction with the NPC. Therefore,
it would be interesting to examine if complex formation
between MMR proteins in cytoplasm plays a similar
role in subcellular localization. However, it is not clear
whether the piggy-back translocation we observed acts as
a backup mechanism or if it is essential for the regulation
of MMR activity in vivo. But the importance of complex
formation between MMR proteins has been illustrated by
the ﬁnding that some single amino acid substitutions in
both hMLH1 and hMSH2 found in HNPCC patients
disrupt complex formations and show defective nuclear
localization (42; A. Lu ¨ tzen et al., submitted for publica-
tion). None of the hMLH1 mutations were located near
its functional NLS sequence. Several MMR proteins
interact with proteins involved in other repair pathways.
Therefore, it could be speculated that proteins involved in
other repair systems could be involved in the translocation
of MMR proteins, thus, linking nuclear translocation of
repair systems.
SUPPLEMENTARY DATA
Supplementary data is available at NAR online.
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